|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-7-27
|
|
pubmed:abstractText |
Menstrually associated migraine (MAM) is often prolonged and difficult to manage with conventional therapies. Frovatriptan is a new selective 5HT(1B/1D) receptor agonist indicated for short-term management of migraine. It has a long half-life and good tolerability. These characteristics suggest that frovatriptan may be useful for the intermittent prevention of MAM.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Carbazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, Combined,
http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Tryptamines,
http://linkedlifedata.com/resource/pubmed/chemical/frovatriptan
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1526-632X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
27
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15277618-Adult,
pubmed-meshheading:15277618-Carbazoles,
pubmed-meshheading:15277618-Contraceptives, Oral, Combined,
pubmed-meshheading:15277618-Contraceptives, Oral, Hormonal,
pubmed-meshheading:15277618-Cross-Over Studies,
pubmed-meshheading:15277618-Double-Blind Method,
pubmed-meshheading:15277618-Drug Administration Schedule,
pubmed-meshheading:15277618-Estrogens,
pubmed-meshheading:15277618-Female,
pubmed-meshheading:15277618-Humans,
pubmed-meshheading:15277618-Hyperacusis,
pubmed-meshheading:15277618-Incidence,
pubmed-meshheading:15277618-Menstrual Cycle,
pubmed-meshheading:15277618-Migraine Disorders,
pubmed-meshheading:15277618-Nausea,
pubmed-meshheading:15277618-Patient Compliance,
pubmed-meshheading:15277618-Photophobia,
pubmed-meshheading:15277618-Serotonin Receptor Agonists,
pubmed-meshheading:15277618-Treatment Outcome,
pubmed-meshheading:15277618-Tryptamines
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
|
|
pubmed:affiliation |
Thomas Jefferson University, Philadelphia, PA, USA. Stephen.Silberstein@Jefferson.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
